PTSD and medication

The Pentagon is set to make a move to limit the off-label use of anti-psychotic medication for the treatment of post-traumatic stress disorder, as this has been associated with accidental drug overdoses among troops.

In a letter to the services in February, Dr. Jonathan Woodson, Assistant Secretary of Defense for Health Affairs, asked for the monitoring of prescriptions of atypical antipsychotics by military treatment facilities. These drugs include risperidone and quetiapine, marketed under the brand name Seroquel. Read more at

http://blog.usnavyseals.com/2012/05/pentagon-to-limit-prescriptions-of-antipsychotic-medication-for-ptsd.html